Using QGenome To Determine Eligibility For Anastrazole – Guidance For Primary Care

The Medicines and Healthcare products Regulatory Agency have recently licensed Anastrazole as a preventive option for women at moderate or high risk of breast cancer due to their family history.

Anastrozole: Thousands to be offered drug to prevent breast cancer in England
https://www.bbc.co.uk/news/health-67337081

Tens of thousands of women set to benefit from ‘repurposed’ NHS drug to prevent breast cancer

https://www.england.nhs.uk/2023/11/tens-of-thousands-of-women-set-to-benefit-from-repurposed-nhs-drug-to-prevent-breast-cancer

Women are therefore being advised to contact their GP who can refer them to a specialist for a full risk assessment taking into account family history.

As a result, General Practitioners will need to manage the increased demand from patients for a formal breast cancer risk assessment whilst dealing with the multitude of other conditions they see in their day-to-day clinical practice.

Primary care clinicians need quick readily-accessible guidance which is where QGenome can help.

QGenome is a clinical decision support tool, freely available on iOS, Android or via a Web App. The tool provides dedicated Breast Cancer decision workflows for the following areas:

Referral guidance

Provides a simple brief framework of questions relating to the patient's personal and family history to help users decide whether a patient requires onward referral to tertiary genetics services or whether the patient can be managed within primary or secondary care.

Risk assessment

Used to generate a risk assessment based on personal and family history information that has been entered by the user. The risk assessment states the patient’s risk level, what risk-reducing options are available and where the patient should be referred for further management.

Genomic testing

Used to determine a patient's eligibility for genomic testing. Encompasses inherited/rare disease and cancer genomic testing criteria aligned with the NHSE national genomic test directory and provides quick links to key documents, for example genomic test request and consent forms.

Determining Eligibility for Anastrazole

QGenome can support your breast cancer family history consultations in clinic and ensure women who are eligible for Anastrazole can access it in a timely way. We have put together the following guide to help get you started:

Quick Start Guide

QGenome - A quick start guide... — QGenome

Further Information

Website
www.qgenome.co.uk

Web App
https://app.qgenome.co.uk

iOS
https://apps.apple.com/gb/app/quest-genomics/id999802455

Android
https://play.google.com/store/apps/details?id=com.ubqo.cancergenetics

Alexander Kenney